Accessibility Menu
International Biotechnology Trust Plc logo

International Biotechnology Trust Plc

(LSE) IBT

Current Price£10.50
Market Cap£327.83M
Since IPO (1994)+1,519%
5 Year+39%
1 Year+74%
1 Month+5%

International Biotechnology Trust Plc Financials at a Glance

Market Cap

£327.83M

Revenue (TTM)

£117.04M

Net Income (TTM)

£94.81M

EPS (TTM)

£2.40

P/E Ratio

4.29

Dividend

£0.32

Beta (Volatility)

0.04 (Low)

Price

£10.50

Volume

50,891

Open

£10.40

Previous Close

£10.50

Daily Range

£10.22 - £10.50

52-Week Range

£5.84 - £10.50

Estimated Earnings Date

Nov 10, 2026

IBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About International Biotechnology Trust Plc

Industry

Capital Markets

Employees

0

Headquarters

London, WC2B 6ST, GB

IBT Financials

Key Financial Metrics (TTM)

Gross Margin

81.42%

Operating Margin

80.59%

Net Income Margin

82.27%

Return on Equity

27.35%

Return on Capital

-0.01%

Return on Assets

22.24%

Earnings Yield

23.31%

Dividend Yield

3.09%

Payout Ratio

13.67%

Stock Overview

Market Cap

£327.83M

Shares Outstanding

31.83M

Volume

50.89K

Avg. Volume

46.05K

Financials (TTM)

Gross Profit

£100.05M

Operating Income

£95.60M

EBITDA

£96.41M

Operating Cash Flow

-£9.37M

Capital Expenditure

-£31.30M

Free Cash Flow

-£42.89M

Cash & ST Invst.

£2.97M

Total Debt

£29.75M

International Biotechnology Trust Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£87.88M

+171.1%

Gross Profit

£85.41M

+215.2%

Gross Margin

97.18%

N/A

Market Cap

£327.83M

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

£85.43M

+201.5%

EBITDA

£85.91M

+195.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£2.97M

-67.8%

Total Debt

£29.75M

+7.5%

Accounts Receivable

£241.00K

-96.3%

Inventory

£0.00

N/A

Long Term Debt

£0.00

-100.0%

Short Term Debt

£29.75M

+7.5%

Return on Assets

22.24%

N/A

Return on Invested Capital

23.82%

N/A

Free Cash Flow

-£3.93M

-115.4%

Operating Cash Flow

-£3.93M

-115.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BIOG.LThe Biotech Growth Trust PLC
£14.84+2.49%
BSV.LBritish Smaller Companies VCT plc
£0.72+0.00%
ARR.LAurora Investment Trust plc
£2.41+1.26%
STS.LSTS Global Income & Growth Trust PLC
£2.24+0.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
WENWendy's
$7.96+0.27%
INTCIntel
$130.56-0.01%
PLSMPulsenmore
$9.47+1.78%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.32+0.02%

Questions About IBT

What is the current price of International Biotechnology Trust Plc?

International Biotechnology Trust Plc is trading at £10.50 per share.

What is the 52-week range for International Biotechnology Trust Plc?

Over the past 52 weeks, International Biotechnology Trust Plc has traded between £5.84 and £10.50.

How much debt does International Biotechnology Trust Plc have?

As of the most recent reporting period, International Biotechnology Trust Plc reported total debt of £29.61M.

How much cash does International Biotechnology Trust Plc have on hand?

International Biotechnology Trust Plc reported £14.98M in cash and cash equivalents in its most recent financial results.

What is International Biotechnology Trust Plc’s dividend yield?

International Biotechnology Trust Plc currently has a dividend yield of 3.09%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.